E25Bio

E25Bio is a company that has developed a paper-based diagnostic platform for detecting viral antigens during infection. The platform offers multiplexed tests that can be captured by a mobile phone application for real-time data reporting and analytics. This enables governments to accurately identify viral diseases such as zika virus, dengue, chikungunya, and novel coronavirus at the point of care at an affordable cost. E25Bio's platform can effectively prevent an outbreak from turning into a public health crisis.